NovaQuest Capital Management
NovaQuest Capital Management, based in Raleigh, North Carolina, is a private equity firm that specializes in investments within the global healthcare sector. Founded in 2000, NovaQuest primarily focuses on structured finance investments in late-stage clinical and commercial biopharmaceutical products, collaborating closely with global companies to enhance the value of their product portfolios. The firm also invests in select private equity and other company securities, maintaining a consistent emphasis on late-stage clinical and commercialized products. Over its history, NovaQuest has invested more than $1 billion in the healthcare industry, leveraging an experienced team that has worked together for over 12 years. The firm's investment strategy, developed through years of experience, utilizes a tailored approach to meet the evolving needs of healthcare companies and their investors. NovaQuest manages several funds, including co-investment and direct lending funds, targeting various sectors such as pharmaceuticals, biotechnology, and life sciences.
Applied Lifesciences & Systems, LLC is a bio-systems company based in Raleigh, North Carolina, established in 2011. The company specializes in developing automated solutions for the detection, targeting, and delivery of vaccines in the poultry, aquaculture, and livestock sectors. Its innovative vaccine delivery system aims to enhance current vaccination methods by ensuring that each chick receives an accurate and consistent vaccination. This precision not only boosts the natural immune response to diseases but also improves overall flock health, contributing to cleaner and healthier poultry. Applied Lifesciences & Systems is committed to advancing animal health and productivity through its cutting-edge technology.
Private Equity Round in 2021
Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases.
Pro-ficiency is a leading provider of tech-enabled training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including a turn-key offering of customized, virtual training simulations, training, and compliance monitoring tools, and real-time data & predictive analytics.
Private Equity Round in 2018
Clinical Ink, Inc. specializes in providing eSource and patient engagement solutions tailored for the clinical research sector, assisting sites, sponsors, and contract research organizations (CROs) in streamlining their processes. The company's primary offering, SureSource, is an electronic source platform designed to capture essential clinical trial data and documents directly at the research site. Additionally, Clinical Ink provides Lunexis ePRO+, which facilitates patient participation by allowing flexible engagement options, and CentrosHealth, a platform that keeps patients informed and compliant throughout their clinical trial experience. Founded in 2006, Clinical Ink operates its headquarters in Horsham, Pennsylvania, and has additional offices in Winston-Salem, Cary, Philadelphia, and Cambridge. The company aims to enhance clinical trial workflows and improve data quality through its innovative electronic source solutions.
Viamet Pharmaceuticals specializes in the discovery and development of novel therapeutic agents targeting metalloenzymes through its proprietary Metallophile™ Technology. This innovative approach leverages the company’s expertise in bioinorganic chemistry to develop inhibitors that demonstrate significant therapeutic and commercial potential. Viamet focuses on creating best-in-class analogs of existing metalloenzyme inhibitors, which allows for the rapid and cost-effective generation of patentable small molecule compounds. The company’s therapeutic pipeline addresses critical health challenges, including invasive fungal infections, cancer, cardiovascular conditions, and orphan diseases, by targeting the body's ability to utilize essential metal ions such as zinc and iron.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.